239 related articles for article (PubMed ID: 26536977)
1. Immune-mediated Skin Inflammation is Similar in Severe Atopic Dermatitis Patients With or Without Filaggrin Mutation.
Dajnoki Z; Béke G; Mócsai G; Kapitány A; Gáspár K; Hajdu K; Emri G; Nagy B; Kovács I; Beke L; Dezső B; Szegedi A
Acta Derm Venereol; 2016 Jun; 96(5):645-50. PubMed ID: 26536977
[TBL] [Abstract][Full Text] [Related]
2. Severe skin inflammation and filaggrin mutation similarly alter the skin barrier in patients with atopic dermatitis.
Mócsai G; Gáspár K; Nagy G; Irinyi B; Kapitány A; Bíró T; Gyimesi E; Tóth B; Maródi L; Szegedi A
Br J Dermatol; 2014 Mar; 170(3):617-24. PubMed ID: 24251354
[TBL] [Abstract][Full Text] [Related]
3. IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation.
Floudas A; Saunders SP; Moran T; Schwartz C; Hams E; Fitzgerald DC; Johnston JA; Ogg GS; McKenzie AN; Walsh PT; Fallon PG
J Immunol; 2017 Jul; 199(2):707-717. PubMed ID: 28615416
[TBL] [Abstract][Full Text] [Related]
4. Cytokine modulation of atopic dermatitis filaggrin skin expression.
Howell MD; Kim BE; Gao P; Grant AV; Boguniewicz M; Debenedetto A; Schneider L; Beck LA; Barnes KC; Leung DY
J Allergy Clin Immunol; 2007 Jul; 120(1):150-5. PubMed ID: 17512043
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment:keratinocytes in atopic dermatitis - their pathogenic involvement.
Komine M
J Pharmacol Sci; 2009 Jul; 110(3):260-4. PubMed ID: 19609063
[TBL] [Abstract][Full Text] [Related]
6. Topical Glucose Induces Claudin-1 and Filaggrin Expression in a Mouse Model of Atopic Dermatitis and in Keratinocyte Culture, Exerting Anti-inflammatory Effects by Repairing Skin Barrier Function.
Yamada K; Matsushita K; Wang J; Kanekura T
Acta Derm Venereol; 2018 Jan; 98(1):19-25. PubMed ID: 28967978
[TBL] [Abstract][Full Text] [Related]
7. Topical application of celastrol alleviates atopic dermatitis symptoms mediated through the regulation of thymic stromal lymphopoietin and group 2 innate lymphoid cells.
Lee JK; Seok JK; Cho I; Yang G; Kim KB; Kwack SJ; Kang HC; Cho YY; Lee HS; Lee JY
J Toxicol Environ Health A; 2021 Nov; 84(22):922-931. PubMed ID: 34304725
[TBL] [Abstract][Full Text] [Related]
8. IL-1β induces thymic stromal lymphopoietin and an atopic dermatitis-like phenotype in reconstructed healthy human epidermis.
Bernard M; Carrasco C; Laoubi L; Guiraud B; Rozières A; Goujon C; Duplan H; Bessou-Touya S; Nicolas JF; Vocanson M; Galliano MF
J Pathol; 2017 Jun; 242(2):234-245. PubMed ID: 28191908
[TBL] [Abstract][Full Text] [Related]
9. Genetics of atopic dermatitis: beyond filaggrin-the role of thymic stromal lymphopoietin in disease persistence.
Duchatelet S; Hovnanian A
JAMA Dermatol; 2014 Mar; 150(3):248-50. PubMed ID: 24402650
[No Abstract] [Full Text] [Related]
10. Eupatilin, an activator of PPARα, inhibits the development of oxazolone-induced atopic dermatitis symptoms in Balb/c mice.
Jung Y; Kim JC; Park NJ; Bong SK; Lee S; Jegal H; Jin LT; Kim SM; Kim YK; Kim SN
Biochem Biophys Res Commun; 2018 Feb; 496(2):508-514. PubMed ID: 29353040
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity.
Saunders SP; Moran T; Floudas A; Wurlod F; Kaszlikowska A; Salimi M; Quinn EM; Oliphant CJ; Núñez G; McManus R; Hams E; Irvine AD; McKenzie AN; Ogg GS; Fallon PG
J Allergy Clin Immunol; 2016 Feb; 137(2):482-91. PubMed ID: 26299987
[TBL] [Abstract][Full Text] [Related]
12. Skin pH Is the Master Switch of Kallikrein 5-Mediated Skin Barrier Destruction in a Murine Atopic Dermatitis Model.
Jang H; Matsuda A; Jung K; Karasawa K; Matsuda K; Oida K; Ishizaka S; Ahn G; Amagai Y; Moon C; Kim SH; Arkwright PD; Takamori K; Matsuda H; Tanaka A
J Invest Dermatol; 2016 Jan; 136(1):127-35. PubMed ID: 26763432
[TBL] [Abstract][Full Text] [Related]
13. Influence of FLG mutations and TSLP polymorphisms on atopic dermatitis onset age.
Wan J; Mitra N; Hoffstad OJ; Margolis DJ
Ann Allergy Asthma Immunol; 2017 Jun; 118(6):737-738.e1. PubMed ID: 28479194
[No Abstract] [Full Text] [Related]
14. Thymic stromal lymphopoietin variation, filaggrin loss of function, and the persistence of atopic dermatitis.
Margolis DJ; Kim B; Apter AJ; Gupta J; Hoffstad O; Papadopoulos M; Mitra N
JAMA Dermatol; 2014 Mar; 150(3):254-9. PubMed ID: 24401911
[TBL] [Abstract][Full Text] [Related]
15. The association between phthalate exposure and atopic dermatitis with a discussion of phthalate induced secretion of interleukin-1β and thymic stromal lymphopoietin.
Overgaard LE; Bonefeld CM; Frederiksen H; Main KM; Thyssen JP
Expert Rev Clin Immunol; 2016 Jun; 12(6):609-16. PubMed ID: 26894419
[TBL] [Abstract][Full Text] [Related]
16. [Pathogenesis of atopic dermatitis].
Lang C; Kypriotou M; Christen-Zaech S
Rev Med Suisse; 2010 Apr; 6(246):860-2, 864-5. PubMed ID: 20455383
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.
Suárez-Fariñas M; Dhingra N; Gittler J; Shemer A; Cardinale I; de Guzman Strong C; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2013 Aug; 132(2):361-70. PubMed ID: 23777851
[TBL] [Abstract][Full Text] [Related]
18. Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin.
Pellerin L; Henry J; Hsu CY; Balica S; Jean-Decoster C; Méchin MC; Hansmann B; Rodriguez E; Weindinger S; Schmitt AM; Serre G; Paul C; Simon M
J Allergy Clin Immunol; 2013 Apr; 131(4):1094-102. PubMed ID: 23403047
[TBL] [Abstract][Full Text] [Related]
19. Thymic stromal lymphopoietin-activated invariant natural killer T cells trigger an innate allergic immune response in atopic dermatitis.
Wu WH; Park CO; Oh SH; Kim HJ; Kwon YS; Bae BG; Noh JY; Lee KH
J Allergy Clin Immunol; 2010 Aug; 126(2):290-9, 299.e1-4. PubMed ID: 20624642
[TBL] [Abstract][Full Text] [Related]
20. Thymic stromal lymphopoietin links keratinocytes and dendritic cell-derived IL-23 in patients with psoriasis.
Volpe E; Pattarini L; Martinez-Cingolani C; Meller S; Donnadieu MH; Bogiatzi SI; Fernandez MI; Touzot M; Bichet JC; Reyal F; Paronetto MP; Chiricozzi A; Chimenti S; Nasorri F; Cavani A; Kislat A; Homey B; Soumelis V
J Allergy Clin Immunol; 2014 Aug; 134(2):373-81. PubMed ID: 24910175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
